Michael H. Goldstein - Net Worth and Insider Trading
Michael H. Goldstein Net Worth
The estimated net worth of Michael H. Goldstein is at least $272,272 dollars as of 2024-11-13. Michael H. Goldstein is the Chief Medical Officer of Ocular Therapeutix Inc and owns about 25,686 shares of Ocular Therapeutix Inc (OCUL) stock worth over $272,272. Details can be seen in Michael H. Goldstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael H. Goldstein has not made any transactions after 2019-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael H. Goldstein
Michael H. Goldstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael H. Goldstein owns 2 companies in total, including Ocular Therapeutix Inc (OCUL) , and Applied Genetic Technologies Corp (AGTC) .
Click here to see the complete history of Michael H. Goldstein’s form 4 insider trades.
Insider Ownership Summary of Michael H. Goldstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2019-05-28 | Chief Medical Officer |
| AGTC | Applied Genetic Technologies Corp | 2016-12-01 | Chief Medical Officer |
Michael H. Goldstein Latest Holdings Summary
Michael H. Goldstein currently owns a total of 1 stock. Michael H. Goldstein owns 25,686 shares of Ocular Therapeutix Inc (OCUL) as of May 28, 2019, with a value of $272,272.
Latest Holdings of Michael H. Goldstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2019-05-28 | 25,686 | 10.60 | 272,272 |
Holding Weightings of Michael H. Goldstein
Michael H. Goldstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael H. Goldstein has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the acquisition of 12,000 shares on May 28, 2019, which cost Michael H. Goldstein around $30,120.
Insider Trading History of Michael H. Goldstein
- 1
Michael H. Goldstein Trading Performance
GuruFocus tracks the stock performance after each of Michael H. Goldstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael H. Goldstein is 34.8%. GuruFocus also compares Michael H. Goldstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael H. Goldstein within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael H. Goldstein's insider trading performs compared to the benchmark.
Performance of Michael H. Goldstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.51 | | | | | |
| Relative Return to S&P 500(%) | 30.56 | | | | | |
Michael H. Goldstein Ownership Network
Ownership Network List of Michael H. Goldstein
Ownership Network Relation of Michael H. Goldstein
Michael H. Goldstein Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Michael H. Goldstein is the Chief Medical Officer of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Michael H. Goldstein made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .
In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Michael H. Goldstein Mailing Address
Above is the net worth, insider trading, and ownership report for Michael H. Goldstein. You might contact Michael H. Goldstein via mailing address: C/o Agtc, 14193 Nw 119th Terrace, Suite #10, Alachua Fl 32615.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
